Fluocortolone caproate

DB15821InvestigationalSmall molecule

Fluocortolone caproate is a corticosteroid indicated in the treatment of hemorrhoids, anal fissures, and corticosteroid-responsive dermatoses. A medication used to treat hemorrhoids and a wide variety of skin conditions.

Formula / weight: C₂₈H₃₉FO₅ · 474.613 g/mol (avg)
Also known as: Fluocortolone 21-caproate · Fluocortolone 21-hexanoate · Fluocortolone hexanoate
Code names: SH-770

Resolves to

Compound

UNII90893P8662CAS303-40-2ChEMBLCHEMBL2107415

Clinical / RWD

RxNorm4464

Structure

InChIKeyWHZRCUIISKRTJL-YTZKRAOUSA-NSMILES[H][C@@]12C[C@@H](C)[C@H](C(=O)COC(=O)CCCCC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C

What you can answer from here — as of March 06, 2025

507Drug interactionsStructured to mechanism, not free text

5Structured indicationsCondition, population, route and combination as fields, not prose

10ContraindicationsEach with its own population and attribute set

22Marketed productsAcross 2 countries and 4 labellers

2+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Fluocortolone caproate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account